Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nimotuzumab”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02945267
What this trial is testing

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Unresectable Pancreatic Cancer
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)UnknownNCT01393184
What this trial is testing

Safety and Efficacy Study of Target Therapy Combined With Radiotherapy to Treat Senile Locally Advanced SCCHN

Who this might be right for
SCCHN
Peking University 92
Testing effectiveness (Phase 2)UnknownNCT01486992
What this trial is testing

MFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus

Who this might be right for
Advanced Esophageal Carcinoma
Peking University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04223024
What this trial is testing

Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 246
Large-scale testing (Phase 3)Ended earlyNCT01813253
What this trial is testing

Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Kuhnil Pharmaceutical Co., Ltd. 400
Testing effectiveness (Phase 2)WithdrawnNCT02011594
What this trial is testing

Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma

Who this might be right for
Stage IV Esophageal Squamous Cell Carcinoma
Zhejiang University
Large-scale testing (Phase 3)Study completedNCT02395016
What this trial is testing

Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)UnknownNCT03708822
What this trial is testing

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 48
Testing effectiveness (Phase 2)Study completedNCT01145170
What this trial is testing

Nimotuzumab and Radiotherapy in Pediatric Patients With Glioma

Who this might be right for
Diffuse Intrinsic Brainstem Gliomas
Eurofarma Laboratorios S.A. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07707973
What this trial is testing

Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual Glioblastoma

Who this might be right for
Glioma, Malignant
Tianjin First Central Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT00369447
What this trial is testing

Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
YM BioSciences 52
Early research (Phase 1)Study completedNCT00369252
What this trial is testing

Phase I Study of Nimotuzumab in Solid Tumours

Who this might be right for
Advanced and/or Metastatic Solid Tumours
YM BioSciences 18
Not applicableStudy completedNCT00561873
What this trial is testing

Nimotuzumab in Children With HGG

Who this might be right for
High Grade Glioma
Oncoscience AG 45
Testing effectiveness (Phase 2)UnknownNCT01516996
What this trial is testing

Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer

Who this might be right for
Oropharyngeal CancerHypopharyngeal Cancer
The Second People's Hospital of Sichuan 80
Not applicableUnknownNCT04678791
What this trial is testing

Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma

Who this might be right for
Cervical Squamous Cell Carcinoma
Peking University Third Hospital 286
Early research (Phase 1)Study completedNCT00950417
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Who this might be right for
Advanced Esophageal
Biotech Pharmaceutical Co., Ltd. 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT06561763
What this trial is testing

TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
High Risk Locally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University 416
Testing effectiveness (Phase 2)UnknownNCT06259721
What this trial is testing

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital 22
Early research (Phase 1)WithdrawnNCT00985998
What this trial is testing

Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd.
Testing effectiveness (Phase 2)UnknownNCT05024019
What this trial is testing

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Eye & ENT Hospital of Fudan University 95
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation